REQUEST A DEMO
Total
USD $0.00
Search more companies

Eurofarma Laboratorios S.A. (Sao Paulo) (Brazil)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Eurofarma Laboratorios S.A. Profile Updated: September 23, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English & Portuguese Download a sample report

The company Eurofarma Laboratorios was founded in 1966, headquartered in the city of Sao Paulo, Brazil. The company operates in the branch of manufacture of medicines for human use.

Headquarters
Av Ver Jose Diniz, 3465, Campo Belo.
Sao Paulo; Sao Paulo; Postal Code: 04603-003

Contact Details: Purchase the Eurofarma Laboratorios S.A. (Sao Paulo) report to view the information.

Website: https://www.eurofarma.com.br/en/

Basic Information
Total Employees:
Purchase the Eurofarma Laboratorios S.A. (Sao Paulo) report to view the information.
Registered Capital:
Purchase the Eurofarma Laboratorios S.A. (Sao Paulo) report to view the information.
Financial Auditors:
Purchase the Eurofarma Laboratorios S.A. (Sao Paulo) report to view the information.
Incorporation Date:
July 05, 1966
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Subsidiaries
Eurofarma Uruguay S.A. (Uruguay)
100%
Incrementha P, D & I Pesquisa, Desenvolvimento e Inovacao de Farmacos e Medicamentos Ltda.
Inova Biotecnologia Saude Animal Ltda.
Company Performance
Financial values in the chart are available after Eurofarma Laboratorios S.A. (Sao Paulo) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BRL. Absolute financial data is included in the purchased report.
Net sales revenue
30.43%
Total operating revenue
30.43%
Operating profit (EBIT)
19.68%
Net Profit (Loss) for the Period
-2.78%
Total assets
35.1%
Total equity
13.19%
Operating Profit Margin (ROS)
-1.38%
Net Profit Margin
-4.09%
Return on Equity (ROE)
-3.84%
Debt to Equity Ratio
40.48%
Quick Ratio
0.56%
Cash Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?